Latest news
Astellas files NDA for fezolinetant in Japan - The Pharma LetterThe Pharma Letter · Sat, 08 Aug 2026 19:29:33 GMTFDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTArrowhead Pharmaceuticals Acquires FDA Priority Review Voucher - Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc. · Tue, 04 Aug 2026 20:01:17 GMTLee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA - TradingViewTradingView · Thu, 30 Jul 2026 15:53:04 GMTAbivax on Track for 2026-end New Drug Application for Ulcerative Colitis Drug - MoomooMoomoo · Thu, 30 Jul 2026 07:00:00 GMTGossamer Bio Plans September New Drug Application Submission for Potential Pulmonary Arterial Hypertension Treatment - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTZhejiang Hisun Pharmaceutical Receives US FDA Abbreviated New Drug Application Approval for Leukemia Injection - MoomooMoomoo · Mon, 27 Jul 2026 07:00:00 GMT